secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2024-02-23T23:59:59+00:00
Accession:  0001023024-24-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals sells former Oakville, ON manufacturing facility for C$19.2M (US$14.2M)
--------------------------------------------------------------------------------

- Purchase price C$19.2M (~US$14.2M); buyer paid 5% deposit (~US$710k) with second 5% after due diligence.
- Buyer has 5 business day due diligence period; closing expected by end of March 2024.
- Sale includes land, building (~101,111 sq ft), chattels and fixtures; sold 'as is' with customary conditions.
- ANI retains deposits if buyer defaults; deposits returned if ANI defaults or due diligence fails.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000015/0001023024-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000015/ani-20240216.htm
  HTML page:      https://secwatch.observer/filing/0001023024-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer